Partnership

All
Insights
Investors
Board of Directors
Leadership
Uncategorized
Our Partners
Scientific Advisory Committee
Cliffs Notes
Trail Notes
Publications
Newsroom

April 10, 2021

Posters & Oral Presentations

Preclinical activity of seribantumab in gastrointestinal cancers with NRG1 fusions

Presented at AACR 2021

Presenting Author: Igor Odintsov, MD; Memorial Sloan Kettering Cancer Center

Read More

March 16, 2021

Press Releases

Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study Read More

February 22, 2021

Infographics

Infographic: PDX Models and Precision Oncology Read More

November 13, 2020

Insights

NRG1 fusions, a (PDX) model challenge Read More

October 26, 2020

Videos

Spotlight on data: Seribantumab in preclinical NRG1 fusion models Read More

October 26, 2020

Posters & Oral Presentations

The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with NRG1 rearrangements

Presented at EORTC-NCI-AACR 2020

Presenting Author: Igor Odintsov, MD; Memorial Sloan Kettering Cancer Center

Read More

Pages: 12Last Page